INTERFERON ALFA-2A OR INTERFERON ALFA-2B for Hepatitis c: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 24 adverse event reports in the FDA FAERS database where INTERFERON ALFA-2A OR INTERFERON ALFA-2B was used for Hepatitis c.
Most Reported Side Effects for INTERFERON ALFA-2A OR INTERFERON ALFA-2B
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 56 | 13.9% | 6 | 8 |
| Off label use | 55 | 13.7% | 6 | 18 |
| Anaemia | 23 | 5.7% | 0 | 18 |
| Neutropenia | 23 | 5.7% | 1 | 10 |
| Fatigue | 15 | 3.7% | 2 | 7 |
| Condition aggravated | 14 | 3.5% | 3 | 5 |
| Headache | 14 | 3.5% | 0 | 2 |
| Drug ineffective for unapproved indication | 13 | 3.2% | 1 | 8 |
| Myelodysplastic syndrome | 13 | 3.2% | 8 | 1 |
| Malignant neoplasm progression | 12 | 3.0% | 6 | 3 |
| Pyrexia | 12 | 3.0% | 2 | 7 |
| Thrombocytopenia | 12 | 3.0% | 0 | 3 |
| Treatment failure | 12 | 3.0% | 0 | 0 |
| Weight decreased | 12 | 3.0% | 2 | 9 |
| Drug intolerance | 11 | 2.7% | 0 | 0 |
Other Indications for INTERFERON ALFA-2A OR INTERFERON ALFA-2B
Renal cell carcinoma (41)
Chronic myeloid leukaemia (32)
Product used for unknown indication (32)
Covid-19 (25)
Plasma cell myeloma (15)
Metastatic renal cell carcinoma (14)
Renal cancer (13)
Chronic hepatitis c (11)
Malignant melanoma (11)
Adenocarcinoma pancreas (8)
Other Drugs Used for Hepatitis c
RIBAVIRIN (20,657)
PEGINTERFERON ALFA-2A (10,970)
LEDIPASVIR\SOFOSBUVIR (8,924)
DASABUVIR\OMBITASVIR\PARITAPREVIR\RITONAVIR (8,264)
SOFOSBUVIR (7,691)
SOFOSBUVIR\VELPATASVIR (4,956)
GLECAPREVIR\PIBRENTASVIR (4,016)
OMBITASVIR\PARITAPREVIR\RITONAVIR (2,906)
TELAPREVIR (2,604)
DASABUVIR (2,603)